CardioNerds discuss GLP-1 receptor agonists in heart disease patients, exploring benefits, guidelines, and trial data. Dr. McGuire explains ease of use and efficacy, emphasizing patient support. They also cover samagletide therapy initiation, dosage levels, and combination therapy with SGLT2 inhibitors for heart failure and diabetes management. Future interventions for obesity and cardiovascular safety are highlighted.